Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography

Heart

Volumn 93, Issue 10, 2007, Pages 1204-1212

  Soliman, Osama I I ^a   Knaapen, Paul ^b   Geleijnse, Marcel L ^a   Dijkmans, Pieter A ^b   Anwar, Ashraf M ^a   Nemes, Attila ^a   Michels, Michelle ^a   Vletter, Wim B ^a   Lammertsma, Adriaan A ^b   Ten Cate, Folkert J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE PERFUSION; HUMAN; HYPEREMIA; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMAGING; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY DISEASE; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 34848878643     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.110460     Document Type: Article

References (39)

1. Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.
2. Olivotto I, Cecchi F, Gistri R, et al. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006;47:1043-8.
3. Schwartzkopff B, Mundhenke M, Strauer BE. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia. J Am Coll Cardiol 1998;31:1089-96.
4. Krams R, Kofflard MJ, Duncker DJ, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 1998;97:230-3.
5. Hittinger L, Mirsky I, Shen YT, et al. Hemodynamic mechanisms responsible for reduced subendocardial coronary reserve in dogs with severe left ventricular hypertrophy. Circulation 1995;92:978-86.
6. Ishida Y, Nagata S, Uehara T, et al. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography. J Cardiol 2001;37(Suppl 1):121-8.
7. Camici P, Chiriatti G, Lorenzoni R, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879- 86.
8. Lorenzoni R, Gistri R, Cecchi F, et al. Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction. Am Heart J 1998;136:972-81.
9. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-83.
10. Tiemann K, Lohmeier S, Kuntz S, et al. Real-time contrast echo assessment of myocardial perfusion at low emission power, first experimental and clinical results using power pulse inversion imaging. Echocardiography 1999;16:799-809.
11. Jayaweera AR, Kaul S. Quantifying myocardial blood flow with contrast echocardiography. Am J Card Imaging 1993;7:317-35.
12. Vogel R, Indermuhle A, Reinhardt J, et al. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol 2005;45:754-62.
13. Dijkmans PA, Knaapen P, Sieswerda GT, et al. Quantification of myocardial perfusion using intravenous myocardial contrast echocardiography in healthy volunteers: comparison with positron emission tomography. J Am Soc Echocardiogr 2006;19:285-93.
14. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 2003;108:1146-62.
15. Sasson Z, Yock PG, Hatle LK, et al. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. J Am Coll Cardiol 1988;11:752-6.
16. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
17. Reichek N, Helak J, Plappert T, et al. Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation 1983;67:348-52.
18. Waggoner AD, Ehler D, Adams D, et al. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: recommendations of the American Society of Echocardiography Council on Cardiac Sonography. J Am Soc Echocardiogr 2001;14:417-20.
19. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
20. Hermansen F, Rosen SD, Farh-Ordoubadi F, et al. Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols. Eur J Nucl Med 1998;25:751-9.
21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
22. Choudhury L, Rosen SD, Patel D, et al. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography. Eur Heart J 1997;18:108-16.
23. Sipola P, Lauerma K, Husso-Saastamoinen M, et al. First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene. Radiology 2003;226:129-37.
24. Kawada N, Sakuma H, Yamakado T, et al. Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects. Radiology 1999;211:129- 35.
25. Kim HK, Kim YJ, Sohn DW, et al. Transthoracic echocardiographic evaluation of coronary flow reserve in patients with hypertrophic cardiomyopathy. Int J Cardiol 2004;94:167-71.
26. Asomi Y, Yoshida K, Hozumi T, et al. [Assessment of coronary flow reserve in patients with hypertrophic cardiomyopathy using transthoracic color Doppler echocardiography]. J Cardiol 1998;32:247-52.
27. Memmola C, Iliceto S, Napoli VF, et al. Coronary flow dynamics and reserve assessed by transesophageal echocardiography in obstructive hypertrophic cardiomyopathy. Am J Cardiol 1994;74:1147-51.
28. Inoue K, Hamada M, Ohtsuka T, et al. Myocardial microvascular abnormalities observed by intravenous myocardial contrast echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 2004;94:55-8.
29. Barron JT, Gu L. Energetic effects of adenosine on vascular smooth muscle. Am J Physiol Heart Circ Physiol 2000;278:H26-32.
30. Lynch FM, Austin C, Heagerty AM, et al. Adenosine- and hypoxia-induced dilation of human coronary resistance arteries: evidence against the involvement of K(ATP) channels. Br J Pharmacol 2006;147:455- 8.
31. Kassab GS, Lin DH, Fung YC. Morphometry of pig coronary venous system. Am J Physiol 1994;267:H2100-13.
32. Watanabe N, Akasaka T, Yamaura Y, et al. Intramyocardial coronary flow characteristics in patients with hypertrophic cardiomyopathy: non-invasive assessment by transthoracic Doppler echocardiography. Heart 2003;89:657-8.
33. Sherrrid MV, Mahenthiran J, Casteneda V, et al. Comparison of diastolic septal perforator flow velocities in hypertrophic cardiomyopathy versus hypertensive left ventricular hypertrophy. Am J Cardiol 2006;97:106-12.
34. Indermuhle A, Vogel R, Meier P, et al. The relative myocardial blood volume differentiates between hypertensive heart disease and athlete's heart in humans. Eur Heart J 2006;27:1571-8.
35. Cannon RO 3rd, Rosing DR, Maron BJ, et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985;71:234-43.
36. Yamakado T, Okano H, Higashiyama S, et al. Effects of nifedipine on left ventricular diastolic function in patients with asymptomatic or minimally symptomatic hypertrophic cardiomyopathy. Circulation 1990;81:593-601.
37. Kaul S, Senior R, Dittrich H, et al. Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99mTc-sestamibi single-photon emission computed tomography. Circulation 1997;96:785-92.
38. Wei K, Crouse L, Weiss J, et al. Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99 m sestamibi single-photon emission computed tomography for detection of coronary artery disease (PB127 Multicenter Phase 2 Trial results). Am J Cardiol 2003;91:1293-8.
39. Chareonthaitawee P, Kaufmann PA, Rimoldi O, et al. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001;50:151-61.